Mechanisms of Liver Failure
Liver failure occurs through a cascade of cellular injury, overwhelming systemic inflammation, immune dysfunction, and multiorgan failure, with the specific pathophysiology varying between acute liver failure (ALF) and acute-on-chronic liver failure (ACLF).
Core Pathophysiological Mechanisms
Acute Liver Failure (ALF)
ALF results from massive hepatocyte death in patients without pre-existing chronic liver disease, triggering a biphasic inflammatory response 1:
- Initial massive hepatocyte necrosis from toxins (acetaminophen most common), viral hepatitis, or other acute insults releases damage-associated molecular patterns
- Systemic inflammatory response syndrome (SIRS) develops first, with excessive proinflammatory cytokine release creating a "cytokine storm"
- Compensatory anti-inflammatory response syndrome (CARS) follows, causing immune cell dysfunction and increased sepsis susceptibility
- Multiorgan failure ensues from combined effects of hepatic synthetic failure, cerebral edema, coagulopathy, and circulatory collapse 2
The liver's central metabolic role means ALF disrupts energy metabolism, protein synthesis, glycemic control, and fat metabolism simultaneously, amplifying systemic dysfunction 1.
Acute-on-Chronic Liver Failure (ACLF)
ACLF represents acute decompensation of cirrhosis with organ failure(s) and 28-day mortality ≥20%, driven by excessive systemic inflammation on a background of chronic liver disease 3.
Key mechanistic features include:
Overwhelming inflammatory response as the central pathogenic driver, often disproportionate to the precipitating event 4
Precipitating events trigger the cascade in 50-60% of cases:
No identifiable precipitant in 40-50% of cases, suggesting genetic predisposition, severe portal hypertension, or subclinical infections as triggers 4
Cellular and Molecular Mechanisms
Mitochondrial dysfunction serves as a central pathogenic driver in both ALF and ACLF 5:
- mtDNA damage and impaired ATP generation
- Disrupted ROS homeostasis creating oxidative stress
- Dysregulated calcium homeostasis
- Impaired mitophagy and mitochondrial biogenesis
- Metabolic shift toward less efficient aerobic glycolysis 6
Immune cell dysfunction perpetuates organ failure 6:
- Monocyte and neutrophil dysfunction with impaired phagocytic capacity
- Metabolic reprogramming of immune cells toward aerobic glycolysis
- Transition from hyperinflammation to immune paralysis
Chronic Liver Disease Progression to Failure
In cirrhosis, architectural destruction precedes acute failure 7:
- Fibrosis progression replaces normal parenchyma with regenerative nodules and fibrous bands
- Vascular distortion causes portal-systemic shunting, impairing hepatotrophic factor delivery to hepatocytes
- Loss of endothelial fenestrations further blocks regenerative factor access
- Impaired regenerative capacity results from these combined architectural changes, increasing PHLF risk to 5-10% (vs. <1% in normal liver) 7
Amplification Loops
The gut-liver axis amplifies systemic inflammation 6:
- Severe dysbiosis and intestinal barrier breakdown
- Bacterial translocation and endotoxin absorption
- Portal endotoxemia triggering sustained hepatic inflammation 8
The liver-spleen axis creates a second amplification loop 6:
- Congested, immunologically remodeled spleen sustains portal hypertension
- Contributes to circulating cytokine pool
- Relays profibrogenic signals back to liver
Endothelial dysfunction becomes generalized, contributing to peripheral organ failure 6.
Critical Clinical Implications
Post-Hepatectomy Liver Failure (PHLF)
When insufficient functional liver remains after resection, specific mechanisms drive failure 7:
- Hepatic ischemia-reperfusion injury during surgery
- Parenchymal congestion in remnant liver
- Reduced phagocytic capacity increasing infection risk
- Small-for-size syndrome: hyperperfusion of inadequate remnant causes shearing forces, centrilobular necrosis, and inhibited cell proliferation 7
Congestive Hepatopathy (FALD)
In Fontan circulation, unique mechanisms drive liver failure 8:
- Chronic venous hypertension transmitted to sinusoids causing dilatation and perisinusoidal edema
- Sinusoidal capillarization from shear stress
- Impaired hepatic arterial buffer response causing chronic hypoxia
- Hepatic sinusoidal thrombosis from prothrombotic state
- Lymphatic congestion contributing to fibrosis
Common Pitfalls
- Underestimating inflammation's role: The cytokine storm in ACLF explains why younger patients often develop this syndrome and why bacterial infections are such potent triggers 4
- Missing subclinical precipitants: Up to 50% of ACLF cases have no obvious trigger, requiring high clinical suspicion for occult infections 4
- Ignoring the biphasic immune response: Initial hyperinflammation transitions to immune paralysis, requiring different management approaches at different disease stages 1, 6
- Overlooking mitochondrial dysfunction: This represents a potentially targetable mechanism across all liver failure types 5